Profile
Sector:
HealthcareIndustry:
Medical DistributionCountry:
ChinaIPO:
12 September 2018Website:
http://www.111.com.cnNext earnings report:
23 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Mon, 01 Jul 2024 17:14:32 GMTDividend
Analysts recommendations
Institutional Ownership
YI Latest News
SHANGHAI , June 11, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, announced that the Company has entered into a strategic direct supply partnership (the "Partnership") with Beijing Scrianen Pharmaceutical Co., Ltd. ("Scrianen"), a comprehensive pharmaceutical enterprise that integrates research and development, production and marketing.
111, Inc. (NASDAQ: YI) will release its unaudited financial results for the first quarter ending on March 31, 2024 before the U.S. market opens on May 23, 2024. The company's management team will conduct an earnings conference call at 7:30 AM U.S. Eastern Time on the same day.
111, Inc. (YI) Q4 2023 Earnings Call Transcript
SHANGHAI , March 1, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2023 ended December 31, 2023, before the U.S. market opens on Thursday, March 21, 2024. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 21, 2024 (7:30 PM Beijing Time on the same day).
SHANGHAI , Nov. 13, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2023, before the U.S. market opens on Thursday, November 30, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, November 30, 2023 (8:30 PM Beijing Time on the same day).
SHANGHAI , May 25, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2023, before the U.S. market opens on Thursday, June 15, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, June 15, 2023 (7:30 PM Beijing Time on the same day).
111, Inc. (NASDAQ:YI ) Q4 2022 Earnings Conference Call March 23, 2023 7:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Harvey Wang - Chief Operating Officer Conference Call Participants Xipeng Feng - CICC Stephen Lee - Individual Investor Tom Craig - Cornerstone Investment Francis Yang - BSV Capital Operator Hello, everyone and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.
What type of business is 111?
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
What sector is 111 in?
111 is in the Healthcare sector
What industry is 111 in?
111 is in the Medical Distribution industry
What country is 111 from?
111 is headquartered in China
When did 111 go public?
111 initial public offering (IPO) was on 12 September 2018
What is 111 website?
https://www.111.com.cn
Is 111 in the S&P 500?
No, 111 is not included in the S&P 500 index
Is 111 in the NASDAQ 100?
No, 111 is not included in the NASDAQ 100 index
Is 111 in the Dow Jones?
No, 111 is not included in the Dow Jones index
When does 111 report earnings?
The next expected earnings date for 111 is 23 August 2024